Application note: Multiplexed automated imaging assay for cardiotoxic compounds using the ImageXpress Pico system
Posted: 13 September 2019 | Molecular Devices | No comments yet
There is an increasing need to expand the variety and complexity of cell-based assays for biologic research and drug discovery.
Stem cell-derived cells and tissues have become an increasingly attractive alternative to traditional in vitro and in vivo testing in pharmaceutical drug development and toxicological safety assessment. In this study, Molecular Devices scientists used human induced pluripotent stem cell (iPSC)-derived cardiomyocytes to develop functional and morphological readouts for testing effects of different compounds in a multi-parametric assay format, using the ImageXpress Pico Automated Cell Imaging System.
Related content from this organisation
- Plasmids: Tackling Supply Chain and Manufacturing Challenges
- Machine Learning and AI in Enhancing Image Analysis of 3D Samples
- Transform your drug discovery pipeline with 3D cellular models
- Translating Promising Drug Candidates from Preclinical Screening to Clinical Trials
- Women in Stem with Vicky Marsh Durban
Related topics
Assays, Stem Cells
Related organisations
Molecular Devices